Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Cll Subclonal'

Cll Subclonal published presentations and documents on DocSlides.

Clonal Evolution in CLL:
Clonal Evolution in CLL:
by karlyn-bohler
Impact . on t. iming . of . therapy. Nicholas Chi...
CLL Stromal cell protect
CLL Stromal cell protect
by tawny-fly
CLL Stromal cell protect Conventional therapies V...
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
by carny
Mallaig. Sprinkling Song . Spirit of God, come dw...
Update on chronic lymphocytic leukemia (CLL) treatment
Update on chronic lymphocytic leukemia (CLL) treatment
by joy
Dr Mona Yuklea. Hematology Department, Meir Hospi...
Case 2012-09
Case 2012-09
by tawny-fly
Diagnostic Slide Session. AANP - Annual Meeting. ...
Chronic lymphocytic leukemia,
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...
Implementing Best Practices in Chronic Lymphocytic Leukemia
Implementing Best Practices in Chronic Lymphocytic Leukemia
by myesha-ticknor
CLL/SLL. Use of Markers in Nonclinical Trial Prac...
Case Study Interpretation
Case Study Interpretation
by lindy-dunigan
Spring 2010. Clinical history. A 62 year old man ...
chronic lymphocytic leukemia
chronic lymphocytic leukemia
by test
is the most common type of . leukemia. . . CLL in...
Mechanisms of
Mechanisms of
by giovanna-bartolotta
Ibrutinib. Sensitivity and Resistance in CLL. Y....
Integration of Novel Therapies in WM and CLL : When and How
Integration of Novel Therapies in WM and CLL : When and How
by giovanna-bartolotta
Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...
Personalized Therapy in Relapsed or Refractory CLL
Personalized Therapy in Relapsed or Refractory CLL
by kittie-lecroy
IWCLL Criteria for Treating CLL. Other Considerat...
Making Sense of Novel Prognostics: NOTCH1, SF3B1
Making Sense of Novel Prognostics: NOTCH1, SF3B1
by olivia-moreira
Jennifer R Brown, MD PhD. Director, CLL Center. D...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Interesting case conference
Interesting case conference
by natalia-silvester
Mary-Margaret Allen, MD. February 24, 2015. 58 . ...
Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP
Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP
by ellena-manuel
Pharmacist Focus on BTK Inhibitors Moderator Shil...
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
by windbey
δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...
Curriculum Guide 2012 French I
Curriculum Guide 2012 French I
by audrey
Unit Objectives Approx 15 week per unit New Essent...
www.society -for- hematopathology.org
www.society -for- hematopathology.org
by yvonne
SH2021-XX . Marrow involvement by clonally-related...
C hronic lymphocytic
C hronic lymphocytic
by della
leukemia. Magdalena Olszewska-Szopa. Definition. C...
Using DNA copy number aberrations to
Using DNA copy number aberrations to
by pamela
identify candidate drivers of . carcinogenesis in ...
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
by susan
Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
by Tigerwoods
Mehrdad. . Payandeh. Department of Hematology and...
Comparison between Time-
Comparison between Time-
by LifeOfTheParty
Limited,Venetoclax. -Based and Continuous Bruton ....
Module 3: Chronic Lymphocytic Leukemia
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
PATIENT EDUCATION
PATIENT EDUCATION
by brooke
Introduction Chronic lymphocytic leukemia (CLL) is...
Chronic Lymphocytic
Chronic Lymphocytic
by caitlin
A Guide for Being diagnosed with Chronic Lymphocy...
Reproducible diagnosis of
Reproducible diagnosis of
by davis
Title: Chronic Lymphocytic Leukemia by flow cyto...
uidelines
uidelines
by stella
Pan - London Haemato - O ncology Clinical G Lymph...
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
by erica
Table1ClinicalandimagingcharacteristicsofBcellindo...
Hima Darapu, MD Princeton Baptist Medical Center
Hima Darapu, MD Princeton Baptist Medical Center
by felicity
Baptist Health systems Alabama. Baseline Flow Cyto...
Dr.V.Shanthi Associate Professor , Pathology
Dr.V.Shanthi Associate Professor , Pathology
by luna
Sri . Venkateswara. Institute of Medical Sciences...
Research To Practice ASH 2022 CLL Updates
Research To Practice ASH 2022 CLL Updates
by erica
John N. Allan. Associate Professor of Clinical Med...
CLL: clinical cases Celso Arrais
CLL: clinical cases Celso Arrais
by genevieve
Conflict of Interests. I declare NO relevant confl...
Former Area Horticulture Agent
Former Area Horticulture Agent
by danika-pritchard
A A , A OBER. CLL DOILY Coordinator, Water Resour...
MatBA: A Targeted Oligonucleotide Array for Assessment of G
MatBA: A Targeted Oligonucleotide Array for Assessment of G
by stefany-barnette
Copy . Number Alterations for Risk Stratification...
IMPACT Project
IMPACT Project
by olivia-moreira
Drag coefficients of Low Earth Orbit satellites c...
Maude et al. BLOOD
Maude et al. BLOOD
by lindy-dunigan
, 25 JUNE 2015 x VOLUME 125, NUMBER 26. Objective...
Thyroid nodule: rst manifestation of chronic lymphocytic leukaemiaAna
Thyroid nodule: rst manifestation of chronic lymphocytic leukaemiaAna
by karlyn-bohler
case report hronic lymphocytic leukaemia (CLL) is ...
YOU VE NY QUESIONS, SE CLL US:
YOU VE NY QUESIONS, SE CLL US:
by tatyana-admore
WHAT’ THT? WHAT D WG? The Boardwalk Condo...